Subject Index

Total Page:16

File Type:pdf, Size:1020Kb

Subject Index Subject Index acanthosis 78, 218, 229, 352 – aeroallergens 59 – fumigatus 418 Acarus siro var. hominis 123 – contact allergens 58 astemizole 497 acid ceramidase 161 – food allergens 58 asthma, see also bronchial asthma 4, acidic syndet 474 alloknesis 223 108, 151, 152, 246, 391 acquired immunodeficiency syndrome alopecia areata 131 –inadults111 (AIDS) 202 alpha-hemolysin 407 – in children 111 acrodermatitis enteropathica 104 alpha-pinene 385 – risk factors 109 activation-induced T cell death Alternaria 396 asthmatic wheezing 434 (AICD) 326 amino acid 479 ataxia teleangiectatica 209 activator protein 332 – exchange 258 atopic – 1 (AP-1) 336 – sequence 340 –airwaydisease511 acupuncture 586, 592 –solution54 – dermatitis adenosintriphosphate 530 amphiphilic emulsion 464 – – descendant family history 215 adhesin 406 amyloidosis 133 ––maternaleffect 215 adrenal cortical hormone 477, 488 anaphylaxis 3 – – paternal effect 215 aeroallergen 54, 59, 296, 299, 395, angiotensin-converting enzyme 307 – eczema 443, 507, 513 anhidrotic congenital ectodermal dys- ––afterchildhood 150 agglutination test 407 plasia (ACED) 129 ––asthma 151 aggravating factors 57 animal model 261, 410 – – climate 507 aggression 548 ankylosing spondylitis 146 – – community samples 150 AIDS 123, 202 anorexia nervosa 162 – – comorbidity 545 air antecubital eczema 38 – – diagnostic criteria 21, 90 – pollen concentration 512 antibacterial – – differential diagnosis 95, 100 – pollution 27, 507, 513 – silver coated textile 496 – – discoid variant 87 airway – therapy 599 ––eczematousskin 218 – eosinophilia 110 anticyclones 511 – – extrinsic/intrinsic subtypes 24 – hyperresponsiveness (AHR) 325, antigen ––familyhistory 213 346 – antigen-presenting cell (APC) 208, – – follicular form 80, 81 alkaline 473 218, 265, 269, 282 – – follicular variant 86 allergen 332 – exposure 450 ––frequencyinadults 22 – allergen-specific immunothera- – uptake 266 – – frequency in children 22 py 438 antihistamine 110, 153, 226, 272, 598 ––hayfever 151 – exposure 435 anti-inflammatory drug 459 ––inchildhood 86 – sensitization 153 anti-ovalbumin 387 ––intrinsictype 154 allergic antipruritics 226 – – intrinsic/non-IgE-associated – asthma 230 antiseptics 495, 599 type 81 – conjunctivitis 125 anti-staphylococcal therapy 493 – – irritant exposure 171 – contact dermatitis (ACD) 168, 178, anxiety 32, 545, 548, 552 ––nummulartype 87 484 apolar emulsion 463 – – occupational guidelines 175 – inflammation, apoptosis 326 apoptosis 326, 421 – – papular lichenoid variant 86, 87 – rhinoconjunctivitis, see also hay apron sign 167 ––papuloustype 37 fever 4, 230, 434 Arabidopsis thaliana 420 – – parental predisposition 24 –shiners68 aristolochic acid 592 ––phases 228 – tissue inflammation 281 aroma therapy 587 ––pollen-sensitive 24 allergy testing 58 Aspergillus 396 ––prevalence 22 606 Subject Index ––prevention 552,601 birch pollen allergy 403, 418 chlorine 528 ––prognosticfactors 27 – birch-pollen-related food 402 chlorpheniramine 503 – – prurigo type 87 blepharoconjunctivitis 125 cholesterol 458 ––riskfactors 24 blood eosinophilia 109, 313 –sulfate362 ––sickleave 170 bone marrow 315 chromametry 392 – – topical therapy 463 – transplantation 350 chromatin 313 ––treatment 18,451 Bowenoid papulosis 122 chromosome – eyelid eczema 74 brain-derived neurotrophic factor –1q21247,297 –familyhistory 213 (BDNF) 359 –3q21247,261 –feet76 breast feeding 26, 47, 437, 449 –5q426 – hand eczema 88, 166, 167 Brocq’s theory 14 – 5q31.33 257 – manifestation 433 bronchial –5q34245 – march 108, 151, 433 –asthma5,317 – 11q13 245 –respiratorydisease – – eosinophilic inflammation 108 – 17q25 247 – – personal history 214 – hyperresponsiveness (BHR) 108, –20p248 – skin diathesis 168, 173 318 –region238 – winter feet 41, 76, 77, 88 ––riskfactors 109 – segment 5q31–32 239 atopiform dermatitis 203 Buckley’s syndrome 207 –Xp23259 atopy budesonide 111 chronic – definition 84 bufexamac 181, 231 – granulomatous disease (CGD) 207, – etiopathophysiology 3 bullous impetigo 116 209 –features61 burning sensation 573 – inflammatory skin disease 100 – patch test (APT) 97, 182, 275, 281, – obstructive pulmonary disease 392, 396, 428, 443, 444 C fiber 222, 305, 427 (COPD) 382 –stigmata70 Ctypelectinfamily 266 – vesicular dyshidrotic hand autoantigen 351 calcineurin 489 eczema 541 autogenic training 550 – inhibitor 282 chymase 307, 352 autoimmune disease 133 calcitonin gene-related peptide fibers chymotrypsin-like enzyme 159 autologous blood therapy 587 (CGRP) 219, 357 ciliary dyskinesia 382 autonomic nervous system 427 calcium chlorid 161 cilomilast 558 axon 357 calcium-binding protein 420 cipamfylline 558 – reflex experimental model 358 Candida albicans 117, 128, 300 Cladosporium 395 azole derivative 599 candidategene 237,238,244,256, Claudine family 184 260, 434 cleansing agent 526 Bcell 269,271,288,412 –study259 climate 511 B lymphocyte 269 candidiasis 101 –chamber382 bacterial carboxypeptidase 307 climatic adaptation 511 – antigen 351 carcinogenicity 600 climatotherapy 508, 513, 516 – infection 115, 436, 599 Caspase-I 185 clinical bacteriology 16 cataract 126 – assessment 21 Bacterium prodigiosum 471 cathepsin G 307 – manifestation 62 Bacteroides vulgatus 452 C-C chemokine 219, 240 cluster chemokine 341 bamboo hair 103 cedar pollen pollinosis 410 coeliac disease 127 barrier cefuroxime 494 cold cream 530 –disruption183 cephalosporin 484 cold-pressure test 547 – dysfunction 368 ceramides 363,366,376,414,458,530 common variable immunodeficiency – function 183 cetirizine 154, 504, 505 (CVID) 206 – homeostasis 332 cheilitis 37, 75, 89 complimentary alternative medicine basidiomycete 446 chemical peeling 161 (CAM) 582 basophils 279,352,392 chemokines 185, 187, 282, 318, 334, congenital ichthyosiform beclomethasone dipropionate 110, 111 340 erythroderma 103 Behcet’s disease 304 – superfamily 340 constitutional stigmata 70, 71 Besnier’s prurigo 13 childhood eczema 39 contact beta-adrenergic blockade 17 Children’s Dermatology Life Quality – allergy(CA) 58,178,429 beta-hemolytic streptococcus 118 Index (CDLQI) 33 – dermatitis 7, 101 betamethasone 572 Children’s Life Quality Index – hypersensitivity 335 Bifidobacterium 450 (CLQI) 33 –urticaria230 bioengineering 392 Chinese herbal medicine 586, 592, contamination 537 bioresonance 587 603 Coombs and Gell classification 6 Birbeck granule 288, 289, 394 chlorhexidine 492 Coprinus comatus 446 Subject Index 607 corneocyte 158, 182, 220, 524 dermatitis, see also atopic dermatitis, early colonization 453 corneodesmosome 220 atopic eczema 4 Early Treatment of the Atopic Child corneotherapy 528 – herpetiformis Duhring (DHD) 101 (ETAC) study 153 cornified cell envelope (CE) 247 – papulosa juvenilis (DPJ) 78 East-West-German differences 23 corticophobia 598 dermatofibrosarcoma 134 E-cadherin 185, 328, 333 corticosteroid 55, 272, 368, 477–479, dermatogenic enteropathy 127 eczema, see also atopic eczema, atopic 561, 571, 598 Dermatology Life Quality Index dermatitis 4 – unwanted effects 482 (DLQI) 33 – herpeticum 43, 53, 118, 119, 230, cortisol 477 dermatomyositis 102 497, 599 cortisone 18, 548 Dermatophagoides pteronyssinnus –infantum40 Corynebacterium acnes 472 278, 392, 395, 396, 507 – molluscatum 120, 121 cosmetics 531 dermatophytic infection 116 – nails 86 costimulatory molecule expression 291 dermatophytosis 101 – of the dorsum penis 76 costs 34 dermocorticophobia 18 – school academy 576 cow’s milk allergy 128, 154, 443 desensitization 17 – vaccinatum 120, 230 cradle cap 45, 228 desloratadine 504, 598 –verrucatum124 Crohn’s disease 127 desquamation 158 eczematous skin lesion 218 cross-contact 537 dexamethasone 308 educationprogramme 35,552,577 crusting 49 diabetes mellitus 144, 162 effector T cell 187 crystalline phase 220 diacylglycerol (DAG)-dependent egg allergy 154 cue-controlled relaxation 551 protein kinase C 336 elicitation phase 186 Cushing syndrome 483 diagnostic criteria 21, 48, 90 elimination diet 535, 537, 600 cutaneous – according to Hanifin and Rajka 91 elucidation 548 – barrier function 459 – according to Ring 91 EMG biofeedback 550 –biopsy51 – according to UK working party 90 emollients 525, 528 –catarrh45 diesel exhaust particulate (DEP) 386, emotional – lymphocyte-associated antigen 507 –expression568 (CLA) 323, 333, 343, 393 diet 535, 600 – problems 31 – lymphoma 129 dietary allergen 16 emulsion bath oil 528 –T-celllymphoma102 DiGeorgi anomaly 104 endometriosis 133 cyclic adenosine monophosphat digestive disturbance 46 endothelial-leukocyte adhesion (cAMP) 547 dimethylsulfoxide (DMSO) 184, 373 molecule-1 (ELAM-1) 307 cyclones 511, 512 dinitrochlorobenzene (DNCB) 178, endotoxin 27 cyclopentanoperhydrophenanthrene 203 –exposure435 484 direct costs 34 endurance training 517 cyclosporin 33, 34, 318, 368, 368, 540, dirty neck sign 77 Enterococcus faecalis 452 602 disease gene discovery 256 environmental cystic fibrosis (CF) 127 disseminated wart 123 –allergen420,433 cytokine 185, 187, 307, 315, 318, 350, domestic allergen exposure 435 – control 601 351, 377 Dorfman-Chanarin syndrome 289 – pollution 376 – gene cluster 257 double-blind placebo-controlled food – tobacco smoke (ETS) 385 –production336 challenge (DBPCFC) 400, 536 envoplakin 366 Down’s syndrome 132 enzyme Dactylis glomerata 445 doxepin 226 –chymotrypsin-like159 defensin 531 Drosophila 419, 452 –trypsin-like159 delayed-type hypersensitivity 186, drug sensitivity 130 eosinophil 112,299,300,305,313, 324, 350 dry skin, see also xerosis 63, 83, 89, 317, 351, 392, 428, 560 dendritic cell (DC) 185, 265, 267, 288, 157–163, 183, 219, 457, 524 –activation317
Recommended publications
  • Dissertation Stefan Heinmüller FINAL
    TECHNISCHE UNIVERSITÄT MÜNCHEN Institut für Allgemeinmedizin (Direktor: Univ.-Prof. Dr. Antonius Schneider) Inhalte, Qualität und Ergebnisse von randomisierten kontrollierten Studien der universitären Allgemeinmedizin in Deutschland – ein systematischer Review von 2000 bis 2014 Stefan Philipp Heinmüller Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. Jürgen Schlegel Prüfer der Dissertation: 1. apl. Prof. Dr. Klaus Linde 2. Univ.-Prof. Dr. Antonius Schneider Die Dissertation wurde am 08.02.2017 bei der Technischen Universität München eingereicht und durch die Fakultät für Medizin am 21.02.2018 angenommen. Meinen Großeltern Erika und Dr. Werner Heinmüller aus Mansbach Inhaltsverzeichnis 1 Einleitung und Zielsetzung ........................................................................................ 1 1.1 Bedeutung der Hausarztmedizin ....................................................................... 1 1.2 Notwendigkeit der Forschung in der Allgemeinmedizin sowie deren universitärer Anbindung ..................................................................................... 2 1.3 Historische Entwicklung der akademischen Allgemeinmedizin in Deutschland ......................................................................................................... 3 1.4 Herausforderungen der universitären Allgemeinmedizin ............................... 5 2 Methodik ....................................................................................................................
    [Show full text]
  • Atopic, Contact, and Stasis Dermatitis
    9/2/2017 Atopic, Contact, and Stasis Dermatitis Atopic, Contact, and Stasis Dermatitis Debra Sibbald, BScPhm, ACPR, MA (Adult Education), PhD (Education) Date of Revision: February 2017 Introduction Dermatitis is a nonspecific term describing both acute and chronic skin reactions with corresponding clinical patterns and history. Although the word eczema (boiling over) has been used synonymously with atopic dermatitis, most dermatologists use the term dermatitis to describe an acute, nonspecific skin reaction that exhibits swelling, erythema, scaling, vesicles and crusts. Atopic dermatitis is a chronic inflammatory skin disease caused by mucocutaneous barrier dysfunction. Contact dermatitis is an inflammatory skin reaction caused by exposure to allergens or irritants. Stasis dermatitis is inflammation of the skin of the lower legs caused by chronic venous insufficiency. Skin changes in dermatitis reflect the pattern of inflammatory response. The appearance is similar in all forms of dermatitis, regardless of cause. When the reaction is acute, the earliest and mildest changes are erythema (redness) caused by engorgement and dilatation of the small blood vessels and, usually, swelling (edema) resulting from leakage of fluid from blood vessels and accumulation in tissues. If swelling is severe, skin cells form vesicles that fill with edema fluid; this process is called vesiculation or blistering. Breakage of blisters results in oozing or weeping and evaporation of this fluid causes crusting and scaling. Dermatitis may progress to a chronic
    [Show full text]
  • Complementary Medicine the Evidence So
    Complementary Medicine The Evidence So Far A documentation of our clinically relevant research 1993 - 2010 (Last updated: January 2011) Complementary Medicine Peninsula Medical School Universities of Exeter & Plymouth 25 Victoria Park Road Exeter EX2 4NT Websites: http://sites.pcmd.ac.uk/compmed/ http://www.interscience.wiley.com/journal/fact E-mail: [email protected] Tel: +44 (0) 1392 424989 Fax: +44 (0) 1392 427562 2 PC2/Report/DeptBrochure/Evidence17 14/02/2011 3 Contents 1 Introduction................................................................................................................11 1.1 Background and history of Complementary Medicine...............................................................11 1.2 Aims.................................................................................................................................................11 1.3 Research topics................................................................................................................................11 1.4 Research tools..................................................................................................................................11 1.5 Background on the possibility of closure in May 2011..............................................................12 2 The use of complementary medicine (CM)..............................................................13 2.1 General populations........................................................................................................................13
    [Show full text]
  • Nr 25/20 - 2020.06.15 NO Årgang 110 ISSN 1503-4925
    . nr 25/20 - 2020.06.15 NO årgang 110 ISSN 1503-4925 Norsk varemerketidende er en publikasjon som inneholder kunngjøringer innenfor varemerkeområdet BESØKSADRESSE Sandakerveien 64 POSTADRESSE Postboks 4863 Nydalen 0422 Oslo E-POST [email protected] TELEFON +47 22 38 73 00 8.00-15.45 innholdsfortegnelse og inid-koder 2020.06.15 - 25/20 Innholdsfortegnelse: Meddelelse til søker/innehaver med ukjent adresse ......................................................................................... 3 Registrerte varemerker ......................................................................................................................................... 4 Internasjonale varemerkeregistreringer ............................................................................................................ 38 Ansvarsmerker .................................................................................................................................................. 137 Avgjørelser etter innsigelser ............................................................................................................................ 138 Avgjørelse fra Klagenemnda ............................................................................................................................ 143 Merkeendringer .................................................................................................................................................. 147 Avgjørelse av krav om administrativ overprøving ........................................................................................
    [Show full text]
  • Integration of Complementary and Alternative Medicine Into Family Practices in Germany: Results of a National Survey
    eCAM Advance Access published March 17, 2009 eCAM 2009;Page 1 of 8 doi:10.1093/ecam/nep019 Original Article Integration of Complementary and Alternative Medicine into Family Practices in Germany: Results of a National Survey Stefanie Joos1, Berthold Musselmann1,2 and Joachim Szecsenyi1 1Department of General Practice and Health Services Research, University Hospital Heidelberg, Voßstrasse 2, 69115 Heidelberg and 2Practice of Family Medicine, Academic Teaching Practice, University of Heidelberg, Hauptstrasse 120, 69168 Wiesloch, Germany More than two-thirds of patients in Germany use complementary and alternative medicine (CAM) provided either by physicians or non-medical practitioners (‘Heilpraktiker’). There is little information about the number of family physicians (FPs) providing CAM. Given the widespread public interest in the use of CAM, this study aimed to ascertain the use of and attitude toward CAM among FPs in Germany. A postal questionnaire developed based on qualitatively derived data was sent to 3000 randomly selected FPs in Germany. A reminder letter including a postcard (containing a single question about CAM use in practice and reasons for non-particpation in the survey) was sent to all FPs who had not returned the questionnaire. Of the 3000 FPs, 1027 (34%) returned the questionnaire and 444 (15%) returned the postcard. Altogether, 886 of the 1471 responding FPs (60%) reported using CAM in their practice. A positive attitude toward CAM was indicated by 503 FPs (55%), a rather negative attitude by 127 FPs (14%). Chirotherapy, relaxation and neural therapy were rated as most beneficial CAM therapies by FPs, whereas neural therapy, phytotherapy and acupuncture were the most commonly used therapies in German family practices.
    [Show full text]
  • Gentle Chiropractic
    Gentle Chiropractic 1 Disclaimer Before you start reading this book I must express to you the importance of seeking medical attention when you have strong pain or after you have had an accident, a fall, or injured your back in any other circumstances. It is important to rule out any fractures, ruptures or other conditions that may be detrimental to proceeding with any of the exercises containing in this book. If you are not sure how to do certain exercises ask a health care practitioner, chiropractor or physiotherapist. The information contained in this E Book is educational in nature. The author has made every reasonable effort to ensure that all information is complete, true, correct, appropriate and accurate. However, the information and advice contained in this E Book is not intended as a substitute for consulting your doctor or health care practitioner regarding any action that may affect your well-being. Gentile Chiropractic is –an E Book to refresh the knowledge of chiropractic practitioners and beginners in learning how to do great gentile chiropractic. It is intended as learning and repeating chiropractic only and not as medical or professional advice. Information contained herein is intended to give you the tools to make better gentile chiropractic. Individual readers must assume responsibility for their own actions, safety and health. The author shall not be liable or responsible for any loss, injury, financial consequences or damage what-so-ever allegedly arising from any information, exercise or other suggestion contained in this E Book. I wish you success Christina Reuter 2 © Copyright Christina Reuter • Chiropractor and Naturopath Otto Fischer Weg 2-1 • D-72766 Reutlingen, Germany • Phone +49 (0) 7 121 - 208 343 • [email protected] • www.christina-reuter.de Welcome to the gentile Chiropractic Hello and welcome to the gentile chiropractic.
    [Show full text]
  • 'Male Enhancement', Gender Confirmation Surgery, And
    Technologies of the Natural: ‘Male Enhancement’, Gender Confirmation Surgery, and the ‘Monster Cock’ by Jennifer N.H. Thomas B.A., (Sociology), Pacific University, 2010 B.A., (Spanish), Pacific University, 2010 Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Department of Sociology and Anthropology Faculty of Arts and Social Sciences c Jennifer N.H. Thomas 2020 SIMON FRASER UNIVERSITY Fall 2020 Copyright in this work rests with the author. Please ensure that any reproduction or re-use is done in accordance with the relevant national copyright legislation. Declaration of Committee Name: Jennifer N.H. Thomas Degree: Doctor of Philosophy Thesis title: Technologies of the Natural: ‘Male Enhancement’, Gender Confirmation Surgery, and the ‘Monster Cock’ Committee: Chair: Pamela Stern Associate Professor Sociology & Anthropology Travers Supervisor Professor Sociology & Anthropology Michael Hathaway Committee Member Associate Professor Sociology & Anthropology Coleman Nye Examiner Assistant Professor Gender, Sexuality, and Women’s Studies Susan Stryker External Examiner Distinguished Chair Women’s, Gender, and Sexuality Studies Mills College ii iii Abstract Responding to Susan Stryker’s (2006) call to identify the “seams and sutures” of the ‘natural body’, this dissertation analyzes the social incarnation of the ‘natural male body’ through ‘male enhancement’ discourse in Canada and the United States (247). As one of the few sociological investigations into the medical practice of male enhancement, this research reorients our analytical gaze away from the somatic transformations of historically-oppressed people’s sexed bodies, towards bringing the male body, cis masculinity, and whiteness into the spotlight of critique. This investigation is grounded in fifty hours of online observations of a male enhancement forum for cis men interested in augmenting their genitals; and twenty in-depth, qualitative interviews with medical practitioners who specialize in male enhancement procedures.
    [Show full text]
  • Norsk Varemerketidende Nr 11/19
    . nr 11/19 - 2019.03.11 NO årgang 109 ISSN 1503-4925 Norsk varemerketidende er en publikasjon som inneholder kunngjøringer innenfor varemerkeområdet BESØKSADRESSE Sandakerveien 64 POSTADRESSE Postboks 4863 Nydalen 0422 Oslo E-POST [email protected] TELEFON +47 22 38 73 00 8.00-15.45 innholdsfortegnelse og inid-koder 2019.03.11 - 11/19 Innholdsfortegnelse: Etterlysninger / meddelelse til innehaver med ukjent adresse ......................................................................... 3 Registrerte varemerker ......................................................................................................................................... 4 Internasjonale varemerkeregistreringer ............................................................................................................ 46 Ansvarsmerker .................................................................................................................................................. 133 Innsigelser .......................................................................................................................................................... 134 Avgjørelser etter innsigelser ............................................................................................................................ 137 Avgjørelser fra Klagenemnda........................................................................................................................... 139 Begrensing i varefortegnelsen for internasjonale varemerkeregistreringer ..............................................
    [Show full text]
  • POLICY and PROCEDURE MANUAL Facility-Based Registry Edition
    WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES West Virginia Cancer Registry 2 0 0 7 POLICY AND PROCEDURE MANUAL Facility-Based Registry Edition Bureau for Public Health 350 Capitol Street, Room 125 Charleston, WV 25301 Joe Manchin III, Governor Martha Yeager Walker, Secretary 2007 Policy and Procedure Manual Facility-Based Registry Edition Joe Manchin III Governor Martha Yeager Walker Secretary, Department of Health and Human Resources Chris Curtis, MPH Acting Commissioner, Bureau for Public Health Catherine Slemp, MD, MPH Acting State Health Officer, Bureau for Public Health Joe Barker, MPA Director, Office of Epidemiology and Health Promotion Loretta Haddy, PhD Director, Division of Surveillance and Disease Control Patricia Colsher, PhD Director/Epidemiologist, West Virginia Cancer Registry Cover images courtesy of the National Cancer Institute Visuals Online. Top left: Medulloblastoma. Top right: Ependymoma. Lower left: Oligodendroglioma. Lower right: Glioblastoma. Manual Prepared and Cover Design, Graphics and Layout by: Patricia Colsher, PhD Director/Epidemiologist, West Virginia Cancer Registry Materials Reviewed by: Darlene Maxwell, CTR Leslie Boner, CTR Lee Ann Phalen, CTR WVCR Data Quality Staff WVCR Staff Patricia Colsher, PhD Director/Epidemiologist Darlene Maxwell, CTR Data Quality/Training Leslie Boner, CTR Data Quality/Training Lee Ann Phalen, CTR Data Quality/Training R. Neal Kerley, CTR Systems Management Brenda Shehab Surveillance Stephen Williams Surveillance Judy Arbogast Surveillance Jena Webb Support Services
    [Show full text]
  • Introduction to Bioregulatory Medicine
    Thieme Verlag Sommer-Druck Smit, Introduction to WN 025912/01/01 11.8.2009 Frau Kurz Feuchtwangen Bioregulatory Medicine TN 147611 Index 161 Index A anaerobiosis theory 129 Arndt-Schulz rule 21–22, 113 anergy, Acidum alpha-ketoglutari- Arnica montana 21–22, 74 acetoacetate 98 cum 89 arthritis 157 acetone 98, 99 anthraquinones 108, 117–118, association-induction theory acetyl coenzyme A 84, 85, 97, 98, 121 134–135 99 antibodies, antigen-specific ATP synthetase 106 oxaloacetate metabolism 26–27 autoimmune diseases 156 101–102 antigen presenting cells (APCs) autologous blood therapies 148, Acidum alpha-ketoglutaricum 23, 25, 70–71 155 88–90 antigens 25, 26 autoregulating systems (ARSs) Acidum cis-aconitum 87–88 antihomotoxic medications 45, 2–12, 13 Acidum citricum 83–87 46–47 base rigidity 9, 10 Acidum fumaricum 92–94 availability 145 bipolar feedback systems 4, 6, Acidum succinicum 90–91 classification 142–143 11, 12, 13, 27 acne 158 dosage 146–147 blood glucose regulation 12, aconitase reaction 88 functiotropic 142–143 13 cis-aconitic acid 87–88 multitargeted interven- blood pressure 12 adaptive immune system 70–73 tions 76–77 body temperature 9–12 adenosine diphosphate (ADP) names 145 closed systems 7 105, 106 organotropic 142–143 cybernetics 4–6 adenosine triphosphate (ATP) potencies 146, 147 definition 2 105, 106, 109–110, 112 quinones 113 fluctuating reality 3 adrenal glands, parabenzoquinone selection 145–147 homeostasis 2, 3–4 affinity 119 tolerability 70 homotoxins 35 adrenaline 54 antihomotoxic treatment immune system 69–70 adrenocorticotropic
    [Show full text]
  • The Fifth Annual
    THE FIFTH ANNUAL March 9, 2012 Celebrating the achievements of 8 a.m. – 6 p.m. SDSU student research, March 10, 2012 scholarship and 8 a.m. – 12 p.m. creative activity. Side view of Love Library and Library Addition (looking west) There are only two outside entrances, one to the Library Addition through the Dome (Entrance 1) S N and one to Love Library (Entrance 2) on the south side, 2nd floor behind the glass tunnel. (underground) 1 Love Library (LL) 1st FLOOR Copy Services M (poster printing) Stairs to all LL floors (underground) Donor W Wall Emergency Donor Exit Hall Stairs LL Not to 108 Love Library Scale Elevators Library Addition Women’s Restroom Library Men’s Addition Restroom (outside s S r i t Entrance/Exit a a E i t r s through Dome S on 2nd floor) 4th FLOOR Dome 2nd FLOOR LL LL LL 428D 430 431 LL 260 W M LL LL 261 439 Stairs to all LL floors 2nd floor W M Outside Entrance Stairs to all LL LL LL LL floors 410 408 406 W LL Help Desk STUDENT RESEARCH SYMPOSIUM 2012 2 Library Addition (LA) Glass Tunnel 2nd FLOOR s S r i t a a E i t r s S (underground) W M LA 2203 Entrance/Exit Entrance/Exit Emergency Exit Emergency Donor Hall to Exit Staircase Library Circulation/ 1st FLOOR Reserves Elevator to Desk Library Addition floors s S r t Women’s i a a E i t r Restroom s S W LA Reference Men’s Restroom M Desk 1103 Tutoring Center Not to Scale BASEMENT s S r i t a a E i t r s S W M (LA 61) STUDENT RESEARCH SYMPOSIUM 2012 2012 STUDENT ReseARCH SYMPOSIUM MARCH 9 And 10, 2012 Celebrating the achievements of San Diego State University students
    [Show full text]
  • Proceedings 2017
    Table of Contents 2017 Beacon Conference Program ............................................................................................................ 1 History of the Beacon Conference ........................................................................................................... 21 Outstanding Papers by Panel Allied Health & Nursing ............................................................................................................... 35 Nicholas Belsito: “Multiple Sclerosis and Autologous Hematopoietic Stem Cell Transplantation Treatment” Mentor: Dr. Michele Iannuzzi Sucich, Orange County Community College Anthropology ................................................................................................................................ 50 Melissa Rojas: “Gorillas’ Cognitive and Language Intelligence” Mentor: Professor Shweta Sen, Montgomery College Business and Economics ............................................................................................................... 72 Wyatt Shakespeare: “The LEGO Group’s Corporate Citizenship” Mentors: Professor Elaine Torda and Dr. Russell Hammond, Orange County Community College Empirical Research/Natural Sciences .......................................................................................... 88 Ramsey Marte: “Testing Herbs for Antibacterial Properties” Mentors: Professor Elaine Torda and Dr. Michele Paradies, Orange County Community College Literature ....................................................................................................................................
    [Show full text]